The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial.

Executive Functions Goal achievement Sensory modulation dysfunction Sensory processing Substance use disorder (SUD) Therapeutic community

Journal

Addiction science & clinical practice

ISSN: 1940-0640

Titre abrégé: Addict Sci Clin Pract

Pays: England

ID NLM: 101316917

Informations de publication

Date de publication:
09 Apr 2024

Historique:

received: 17 08 2023

accepted: 07 03 2024

medline: 10 4 2024

pubmed: 10 4 2024

entrez: 9 4 2024

Statut: epublish

Résumé

Substance use disorder (SUD) is associated with executive function (EF) deficits and sensory modulation dysfunction (SMD). Yet, these deficits are not addressed therapeutically. This study aims to examine the effectiveness of the Functional-Cognitive and Sensory Treatment (F-CaST) compared to standard care to improve everyday performance and behavior and length of stay at the therapeutic community (TC) in individuals with SUD. In addition, to assess the improvement in EF, sensory modulation, participation, self-efficacy, life satisfaction, and use of strategies within and between groups. Satisfaction with F-CaST will also be assessed. Forty-eight participants from a community of men in a TC, aged 18-45 years will be randomly allocated to (i) F-CaST-(experimental group) providing sensory and EF strategies for improving daily function; (ii) standard care (control group) as provided in the TC. Assessments will be conducted by assessors blind to group allocation at 4 time points: T1- pre-intervention; T2- post-intervention; T3- 1-month follow-up; and T4- 3-month follow-up. Primary outcome measures will be everyday performance, assessed by the Canadian Occupational Performance Measure (COPM), behavior and length of stay in the TC; secondary outcome measures will assess EF, SMD. Semi-structured in-depth qualitative interviews will be conducted at T1, T2 and T4. We hypothesize that F-CaST will lead to improved everyday performance and longer length of stay in the TC, compared to the control group. If F-CaST will prove to be effective, cognitive and sensory strategies may be incorporated as an adjunctive intervention in SUD rehabilitation. ClinicalTrials.gov NCT05647863 Registered on 13 December 2022, https://classic. gov/ct2/show/NCT05647863 .

Sections du résumé

BACKGROUND BACKGROUND

METHODS METHODS

Forty-eight participants from a community of men in a TC, aged 18-45 years will be randomly allocated to (i) F-CaST-(experimental group) providing sensory and EF strategies for improving daily function; (ii) standard care (control group) as provided in the TC. Assessments will be conducted by assessors blind to group allocation at 4 time points: T1- pre-intervention; T2- post-intervention; T3- 1-month follow-up; and T4- 3-month follow-up. Primary outcome measures will be everyday performance, assessed by the Canadian Occupational Performance Measure (COPM), behavior and length of stay in the TC; secondary outcome measures will assess EF, SMD. Semi-structured in-depth qualitative interviews will be conducted at T1, T2 and T4.

DISCUSSION CONCLUSIONS

We hypothesize that F-CaST will lead to improved everyday performance and longer length of stay in the TC, compared to the control group. If F-CaST will prove to be effective, cognitive and sensory strategies may be incorporated as an adjunctive intervention in SUD rehabilitation.

TRIAL REGISTRATION BACKGROUND

ClinicalTrials.gov NCT05647863 Registered on 13 December 2022, https://classic.

CLINICALTRIALS RESULTS

gov/ct2/show/NCT05647863 .

Identifiants

DOI: 10.1186/s13722-024-00449-7 PMID: 38594737

pubmed: 38594737

doi: 10.1186/s13722-024-00449-7

pii: 10.1186/s13722-024-00449-7

doi:

Banques de données

ClinicalTrials.gov

['NCT05647863']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

Subventions

Organisme : Department of Justice, Estates Committee

ID : 20210605

Informations de copyright

Références

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM–5). Washington, DC: American Psychiatric Association; 2013.

doi: 10.1176/appi.books.9780890425596

Administration. Substance abuse and mental health services. key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Subst Abus Ment Heal Serv Adm. 2021;2021:51–8.

Bar-Or RL, Kor A, Jaljuli I, Lev-Ran S. The epidemiology of substance use disorders among the adult jewish population in Israel. Eur Addict Res. 2021;27(5):362–70.

pubmed: 33730716 doi: 10.1159/000513776

Goplerud E, Hodge S, Benham T. Substance use cost calculator for US employers with an emphasis on prescription pain medication misuse. J Occupationl Environ Med. 2017;59(11):1063.

doi: 10.1097/JOM.0000000000001157

Phelps CL, Paniagua SM, Willcockson IU, Potter JS. The relationship between self-compassion and the risk for substance use disorder. Drug Alcohol Depend. 2018;183:78–81. https://doi.org/10.1016/j.drugalcdep.2017.10.026 .

doi: 10.1016/j.drugalcdep.2017.10.026 pubmed: 29241104

Nardo T, Batchelor J, Berry J, Francis H, Jafar D, Borchard T. Cognitive remediation as an adjunct treatment for substance use disorders: a systematic review. Neuropsychology Review. 2022 Mar;32(1):161-91. https://doi.org/10.1007/s11065-021-09506-3 .

Verdejo-Garcia A, Garcia-Fernandez G, Dom G. Cognition and addiction. Dialogues Clin Neurosci. 2019;21(3):281–90.

pubmed: 31749652 pmcid: 6829168 doi: 10.31887/DCNS.2019.21.3/gdom

Zink N, Lenartowicz A, Markett S. A new era for executive function research: on the transition from centralized to distributed executive functioning. Neurosci Biobehav Rev. 2021;124:235–44.

pubmed: 33582233 pmcid: 8420078 doi: 10.1016/j.neubiorev.2021.02.011

Toglia, J., Katz N. 2018. Executive functioning: Prevention and health promotion for at-risk populations and those with chronic disease. Cognition occupation, and participation across the lifespan: Neuroscience, neurorehabilitation, and models of intervention in occupational therapy, 2018, 129–142.‏ 10.

Manning V, Verdejo-Garcia A, Lubman DI. Neurocognitive impairment in addiction and opportunities for intervention. Curr Opin Behav Sci. 2017;13:40–5. https://doi.org/10.1016/j.cobeha.2016.10.003 .

doi: 10.1016/j.cobeha.2016.10.003

Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–71. https://doi.org/10.1056/NEJMra1511480 .

doi: 10.1056/NEJMra1511480 pubmed: 26816013 pmcid: 6135257

Mckowen J, Carrellas N, Zulauf C, Ward EN, Fried R, Wilens T. Factors associated with attrition in substance using patients enrolled in an intensive outpatient program. Am J Addict. 2017. https://doi.org/10.1111/ajad.12619 .

doi: 10.1111/ajad.12619 pubmed: 28921780

Fernández-Serrano MJ, Pérez-García M, Perales JC, Verdejo-García A. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities. Eur J Pharmacol. 2010;626(1):104–12. https://doi.org/10.1016/j.ejphar.2009.10.019 .

doi: 10.1016/j.ejphar.2009.10.019 pubmed: 19836375

Wilson S, Malone SM, Venables NC, McGue M, Iacono WG. Multimodal indicators of risk for and consequences of substance use disorders: executive functions and trait disconstraint assessed from preadolescence into early adulthood. Int J Psychophysiol. 2021;163:47–57. https://doi.org/10.1016/j.ijpsycho.2019.12.007 .

doi: 10.1016/j.ijpsycho.2019.12.007 pubmed: 31866519

Domínguez-salas S, Díaz-batanero C, Lozano-rojas OM, Verdejo-garcía A. Impact of general cognition and executive function deficits on addiction treatment outcomes: systematic review and discussion of neurocognitive pathways. Neurosci Biobehav Rev. 2016;71:772–801.

pubmed: 27793597 doi: 10.1016/j.neubiorev.2016.09.030

Fernández-serrano MJ, Pérez-garcía M, Verdejo-garcía A. What are the specific vs generalized effects of drugs of abuse on neuropsychological performance ? Neurosci Biobehav Rev. 2011;35:377–406. https://doi.org/10.1016/j.neubiorev.2010.04.008 .

pubmed: 20451551 doi: 10.1016/j.neubiorev.2010.04.008

Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjærn T. Predictors of dropout from inpatient substance use treatment: a prospective cohort study. Subst Abus Res Treat. 2018. https://doi.org/10.1177/1178221818760551 .

doi: 10.1177/1178221818760551

López-goñi JJ, Fernández- Montalvo J, Illescas C, Landa N, Lorea I. Determining socio-demographic predictors of treatment dropout: results in a therapeutic community. Int J Soc Welf. 2008;17(4):374–8.

doi: 10.1111/j.1468-2397.2008.00584.x

Rudnick Frances L, Evans SM, Vosburg SK, Horton T, Brooks D, Ng J. Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav. 2004;29:1875–82.

doi: 10.1016/j.addbeh.2004.03.041

Pastor-Cerezuela G, Fernández-Andrés MI, Sanz-Cervera P, Marín-Suelves D. The impact of sensory processing on executive and cognitive functions in children with autism spectrum disorder in the school context. Res Dev Disabil. 2020;96:1–33.

doi: 10.1016/j.ridd.2019.103540

Adams JN, Feldman HM, Huffman LC, Loe IM. Sensory processing in preterm preschoolers and its association with executive function. Early Hum Dev. 2015;91(3):227–33. https://doi.org/10.1016/j.earlhumdev.2015.01.013 .

doi: 10.1016/j.earlhumdev.2015.01.013 pubmed: 25706317 pmcid: 4392005

Sharfi K, Rosenblum S, Meyer S. Relationships between executive functions and sensory patterns among adults with specific learning disabilities as reflected in their daily functioning. PLoS ONE. 2022;17(4):e0266385. https://doi.org/10.1371/journal.pone.0266385 .

doi: 10.1371/journal.pone.0266385 pubmed: 35390062 pmcid: 8989333

Engel-Yeger B, Rosenblum S. Executive dysfunctions mediate between altered sensory processing and daily activity performance in older adults. BMC Geriatr. 2021;21(1):1–20.

doi: 10.1186/s12877-021-02032-0

Assayag N, Bonneh Y, Parush S, Mell H, Neeman Kaplan R, Bar-Shalita T. Perceived sensitivity to pain and responsiveness to non-noxious sensation in substance use disorder. Pain Med. 2019. https://doi.org/10.1093/pm/pnz292 .

doi: 10.1093/pm/pnz292

Miller LJ, Anzalone ME, Lane SJ, Cermak SA, Osten ET. Concept evolution in sensory integration : a proposed nosology for diagnosis. Am J Occup Ther. 2007;61(2):135–40. https://doi.org/10.5014/ajot.61.2.135 .

pubmed: 17436834 doi: 10.5014/ajot.61.2.135

Greenspan SI, Wieder S. Interdisciplinary Council on Developmental and Learning Disorders–Diagnostic Manual for Infancy and Early Childhood (ICDL-DMIC). Bethesda, MD: ICDL. 2005.

Bar-Shalita T, Vatine JJ, Parush S. Sensory modulation disorder: A risk factor for participation in daily life activities. Dev Med Child Neurol. 2008; 50(12):932–7.

Dunn W, Little L, Dean E, Robertson S, Evans B. The state of the science on sensory factors and their impact on daily life for children : a scoping review. OTJR: Occupation, Participation Health. 2016. https://doi.org/10.1177/1539449215617923 .

doi: 10.1177/1539449215617923 pubmed: 27504990

Bar-Shalita T, Deutsch L, Honigman L, Weissman-Fogel I. Ecological aspects of pain in sensory modulation disorder. Res Dev Disabil. 2015;45–46:157–67. https://doi.org/10.1016/j.ridd.2015.07.028 .

doi: 10.1016/j.ridd.2015.07.028 pubmed: 26254166

Kinnealey M, Koenig KP, Smith S. Relationships between sensory modulation and social supports and health-related quality of life. Am J Occup Ther. 2011;65(3):320–7.

pubmed: 21675338 doi: 10.5014/ajot.2011.001370

Costa-lópez B, Ferrer-cascales R, Ruiz-robledillo N, Albaladejo-blázquez N, Baryła-matejczuk M. Relationship between sensory processing and quality of life: a systematic review. J Clin Med. 2021. https://doi.org/10.3390/jcm10173961) .

doi: 10.3390/jcm10173961) pubmed: 34501408 pmcid: 8432132

Ahn RR, Miller LJ, Milberger S, McIntosh DN. Prevalence of Parents’ perceptions of sensory processing disorders among kindergarten children. Am J Occup Ther. 2004;58(3):287–93.

pubmed: 15202626 doi: 10.5014/ajot.58.3.287

Ben-Sasson A, Carter AS, Briggs-Gowan MJ. Sensory over-responsivity in elementary school: prevalence and social-emotional correlates. J Abnorm Child Psychol. 2009;37(5):705–16.

pubmed: 19153827 pmcid: 5972374 doi: 10.1007/s10802-008-9295-8

Davies PL, Chang WP, Gavin WJ. Middle and late latency ERP components discriminate between adults, typical children, and children with sensory processing disorders. Frontiers in integrative neuroscience. 2010; 4(May):1–9.

Davies PL, Chang W, Gavin WJ. Maturation of sensory gating performance in children with and without sensory processing disorders. Int J Psychophysiol. 2009;72(2):187–97. https://doi.org/10.1016/j.ijpsycho.2008.12.007 .

doi: 10.1016/j.ijpsycho.2008.12.007 pubmed: 19146890

Granovsky Y, Weissman-Fogel I, Bar-Shalita T. Resting-state EEG in individuals with sensory over-responsivity: an exploratory study. Am J Occup Ther. 2018. https://doi.org/10.5014/ajot.2019.029231 .

doi: 10.5014/ajot.2019.029231

Weissman-Fogel I, Granovsky Y, Bar-Shalita T. Sensory over-responsiveness among healthy subjects is associated with a Pronociceptive State. Pain Pract. 2018;18(4):473–86.

pubmed: 28782305 doi: 10.1111/papr.12619

Brett-green BA, Miller LJ, Schoen SA, Nielsen DM. An exploratory event-related potential study of multisensory integration in sensory over-responsive children. Brain Res. 2010;1321:67–77. https://doi.org/10.1016/j.brainres.2010.01.043 .

doi: 10.1016/j.brainres.2010.01.043 pubmed: 20097181

Compton P, Canamar CP, Hillhouse M, Ling W. Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy. J Pain. 2012;13(4):401–9.

pubmed: 22424799 pmcid: 3334366 doi: 10.1016/j.jpain.2012.01.001

Gavin WJ, Dotseth A, Roush KK, Smith CA, Spain HD, Davies PL. Electroencephalography in children with and without sensory processing disorders during auditory perception. Am J Occup Ther. 2011;65(4); 370-377.

Owen JP, Marco EJ, Desai S, Fourie E, Harris J, Hill SS, et al. Clinical Abnormal white matter microstructure in children with sensory processing disorders. Neuroimage. 2013;2:844–53.

pubmed: 24179836 pmcid: 3778265 doi: 10.1016/j.nicl.2013.06.009

Kinnealey M, Oliver B, Wilbarger P. A phenomenological study of sensory defensiveness in adults. Am Occup Ther. 1995;49(5):444–51.

doi: 10.5014/ajot.49.5.444

Bar-shalita T, Granovsky Y, Parush S, Weissman-fogel I. Sensory modulation disorder (SMD) and Pain: a new perspective. Front Integr Neurosci. 2019;13(27):1–10.

Berry J, Jacomb I, Lunn J, Sedwell A, Shakeshaft A, Kelly PJ, et al. A stepped wedge cluster randomised trial of a cognitive remediation intervention in alcohol and other drug (AOD) residential treatment services. BMC Psychiatry. 2019;19(1):1–11.

doi: 10.1186/s12888-019-2044-4

Rezapour T, Hatami J, Farhoudian A, Sofuoglu M, Noroozi A, Daneshmand R, et al. Cognitive rehabilitation for individuals with opioid use disorder: a randomized controlled trial*. Neuropsychol Rehabil. 2019;29(8):1273–89. https://doi.org/10.1080/09602011.2017.1391103 .

doi: 10.1080/09602011.2017.1391103 pubmed: 29161998

Khemiri L, Brynte C, Stunkel A, Klingberg T, Jayaram-Lindström N. Working memory training in alcohol use disorder: a randomized controlled trial. Alcohol Clin Exp Res. 2019;43(1):135–46.

pubmed: 30462837 doi: 10.1111/acer.13910

Ryan DA, Boland P. A scoping review of occupational therapy interventions in the treatment of people with substance use disorders. Irish J Occup Ther. 2021;49(2):104–14.

doi: 10.1108/IJOT-11-2020-0017

Adamit T, Shames J, Rand D. Effectiveness of the functional and cognitive occupational therapy (Faco t) intervention for improving daily functioning and participation of individuals with mild stroke: a randomized controlled trial. Int J Environ Res Public Health. 2021;18(15):7988.

pubmed: 34360299 pmcid: 8345490 doi: 10.3390/ijerph18157988

Adamit T, Shames J, Rand D. Functional and Cognitive Occupational Therapy (FaCoT) improves self-efficacy and behavioral-emotional status of individuals with mild stroke; analysis of secondary outcomes. Int J Environ Res Public Health. 2023;20(6):5052.

pubmed: 36981960 pmcid: 10049253 doi: 10.3390/ijerph20065052

Miller LJ, Reisman JE, McIntosh DN, Simon J. An ecological model of sensory modulation: Performance of children with fragile X syndrome, autistic disorder, attention-deficit/hyperactivity disorder, and sensory modulation dysfunction. Understanding the nature of sensory integration with diverse populations. 2001:57-88.

Cornish JL, Prasad AA. Sex differences in substance use disorders: a neurobiological perspective. Front Glob Women’s Heal. 2021. https://doi.org/10.3389/fgwh.2021.778514 .

doi: 10.3389/fgwh.2021.778514

Falker CG, Stefanovics EA, Rhee TG, Rosenheck RA. Women’s use of substance use disorder treatment services: rates, correlates, and comparisons to men. Psychiatr Q. 2022;93(3):737–52. https://doi.org/10.1007/s11126-022-09989-0 .

doi: 10.1007/s11126-022-09989-0 pubmed: 35661318

Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009;17(5):337–44.

pubmed: 19803633 pmcid: 3144764 doi: 10.1037/a0017260

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.

pubmed: 15817019 doi: 10.1111/j.1532-5415.2005.53221.x

Law M, Baptiste S, Mccoll M, Opzoomer A, Polatajko H, Pollock N. The Canadian occupational performance measure: an outcome measure for occupational therapy. Can J Occup Ther. 1990;57(2):82–7.

pubmed: 10104738 doi: 10.1177/000841749005700207

Eyssen ICJM, Steultjens MPM, Oud TAM, Bol EM, Maasdam A, Dekker J. Responsiveness of the Canadian occupational performance measure. J Rehabil Res Dev. 2011;48(5):517–28.

pubmed: 21674402 doi: 10.1682/JRRD.2010.06.0110

Kjeken I, Dagfinrud H, Uhlig T, Mowinckel P, Kvien TK, Finset A. Reliability of the Canadian occupational performance measure in patients with ankylosing spondylitis. J Rheumatol. 2005;32(8):1503–9.

pubmed: 16078326

Berardi A, Galeoto G, Guarino D, Marquez MA, De Santis R, Valente D, et al. Construct validity, test-retest reliability, and the ability to detect change of the Canadian occupational performance measure in a spinal cord injury population. Spinal Cord Ser Cases. 2019. https://doi.org/10.1038/s41394-019-0196-6 .

doi: 10.1038/s41394-019-0196-6 pubmed: 31632710 pmcid: 6786371

Torpil B, Ekici Çağlar G, Bumin G, Pekçetin S. Validity and Reliability of the Turkish Canadian occupational performance measure (COPM-TR) for people with multiple sclerosis. Occup Ther Heal Care. 2021;35(3):306–17. https://doi.org/10.1080/07380577.2021.1933673 .

doi: 10.1080/07380577.2021.1933673

D'Elia LF, Satz P, Uchiyama CL, White T. Color Trails Test (CTT). Odessa, FL: Psychological Assessment Resources; 1996.

Hartman-Maeir A, Bar-Haim Erez A, Ratzon N, Mattatia T, Weiss P. The validity of the color trail test in the pre-driver assessment of individuals with acquired brain injury. Brain Inj. 2008;22(13–14):994–8.

pubmed: 19117177 doi: 10.1080/02699050802491305

Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dement Geriatr Cogn Disord. 1994. https://doi.org/10.1159/000106735 .

doi: 10.1159/000106735

Siew SKH, Han MFY, Mahendran R, Yu J. Regression-based norms and validation of the cambridge neuropsychological test automated battery among community-living older adults in Singapore. Arch Clin Neuropsychol. 2022;37(2):457–72.

pubmed: 34530442 doi: 10.1093/arclin/acab073

Wang J, Lai Y, Jiang C, Bai Y, Xu B, Du X, et al. Feasibility and validity of Cambridge neuropsychological test automated battery in mild cognitive impairment screening for patients with atrial fibrillation. Comput Math Methods Med. 2022. https://doi.org/10.1155/2022/1527292 .

doi: 10.1155/2022/1527292 pubmed: 36601364 pmcid: 9805395

Roth RM., Isquith PK., Gioia GA, Isquith PK, Gioia GA. (2005). BRIEF-A: Behavior rating inventory of executive function--adult version: Professional manual. Psychological Assessment Resources. 2005

Hagen E, Erga AH, Hagen KP, Nesvåg SM, Mckay JR, Lundervold AJ, et al. Assessment of executive function in patients with substance use disorder : a comparison of inventory- and performance-based assessment. J Subst Abuse Treat. 2016;66:1–8. https://doi.org/10.1016/j.jsat.2016.02.010 .

doi: 10.1016/j.jsat.2016.02.010 pubmed: 27211990

Bar-shalita T, Seltzer Z, Vatine J, Yochman A, Parush S. Development and psychometric properties of the sensory responsiveness questionnaire (SRQ). Disability Rehab. 2009. https://doi.org/10.1080/09638280801903096 .

doi: 10.1080/09638280801903096

Chen G, Gully SM, Eden D. Validation of a new general self-efficacy scale. Organ Res Methods. 2001;4(1):62–83.

doi: 10.1177/109442810141004

Yacoby A, Zeilig G, Weingarden H, Ronit Weiss DR. With video game versus traditional self-training of the upper extremity in people with chronic stroke : a pilot randomized controlled trial. Res Artic. 2019;73(1):1–14.

Rand D, Weingarden H, Weiss R, Yacoby A, Reif S, Malka R, et al. Self-training to improve UE function at the chronic stage post-stroke: a pilot randomized controlled trial. Disabil Rehabil. 2017;39(15):1541–8.

pubmed: 27793071 doi: 10.1080/09638288.2016.1239766

Ownsworth TL, McFarland K, Young RMD. Development and standardization of the self-regulation Skills interview (SRSI): a new clinical assessment tool for acquired brain injury. Clin Neuropsychol. 2000;14(1):76–92.

pubmed: 10855062 doi: 10.1076/1385-4046(200002)14:1;1-8;FT076

Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–56.

pubmed: 15841682 doi: 10.1017/S0033291704002892

Glind G Van De, Oortmerssen KV an E, Carpentier PJAN, Levin FR, Koeter MWJ, Barta C, et al. The International ADHD in Substance Use Disorders Prevalence (IASP) study : background , methods and study population. 2013;22(September):232–44.

Daigre C, Ramos-Quiroga JA, Valero S, Bosch R, Roncero C, Gonzalvo B, et al. Adult ADHD self-report scale (ASRS-V1.1) symptom checklist in patients with substance use disorders. Actas Esp Psiquiatr. 2009;37(6):299–305.

van de Glind G, Konstenius M, Koeter MWJ, van Emmerik-van OK, Carpentier PJ, Kaye S, et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend. 2014;134(1):158–66.

pubmed: 24156882 doi: 10.1016/j.drugalcdep.2013.09.026

Shkedi A. The meaning behind the words: Methodologies of qualitative research. Theory and practice. 2011.

Shkedi A. Multiple case narrative: a qualitative approach to studying multiple populations. Amsterdam: Netherlands John Benjamins; 2005.

doi: 10.1075/sin.7